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study question: Could seminal plasma clusterin play a role in the uptake of stress-damaged proteins by dendritic cells?
summary answer: Seminal plasma clusterin, but not serum clusterin, promotes the uptake of stress-damaged proteins by dendritic cells
via DC-SIGN.
what is known already: Clusterin is one of the major extracellular chaperones. It interacts with a variety of stressed proteins to
prevent their aggregation, guiding them for receptor-mediated endocytosis and intracellular degradation. The concentration of clusterin in
semen is almost 20-fold higher than that found in serum, raising the question about the role of seminal plasma clusterin in reproduction. No pre-
vious studies have analyzed whether seminal plasma clusterin has chaperone activity. We have previously shown that seminal plasma clusterin, but
not serum clusterin, expresses an extreme abundance of fucosylated glycans. These motifs enable seminal plasma clusterin to bind DC-SIGN with
very high affinity.
study design, size, duration: In vitro experiments were performed to evaluate the ability of seminal plasma clusterin to inhibit the
precipitation of stressed proteins, promoting their uptake by dendritic cells via DC-SIGN (a C-type lectin receptor selectively expressed on den-
dritic cells (DC)). Moreover, the ability of seminal plasma clusterin to modulate the phenotype and function of DCs was also assessed.
participants/materials, setting, methods: Clusterin was purified from human semen and human serum. Catalase, bovine
serum albumin, glutathione S-transferase, and normal human serum were stressed and the ability of seminal plasma clusterin to prevent the pre-
cipitation of these proteins, guiding them to DC-SIGN expressed by DCs, was evaluated using a fluorescence-activated cell sorter (FACS). Endo-
cytosis of stressed proteins was analyzed by confocal microscopy and the ability of seminal plasma clusterin-treated DCs to stimulate the
proliferation of CD25+FOXP3+CD4+ T cells was also evaluated by FACS.
main results and the role of chance: Seminal plasma clusterin interacts with stressed proteins, inhibits their aggregation
(P , 0.01) and efficiently targets them to dendritic cells via DC-SIGN (P , 0.01). DCs efficiently endocytosed clusterin-client complexes and
sorted them to degradative compartments involved in antigen processing and presentation. Moreover, we also found that the interaction of
seminal plasma clusterin with DC-SIGN did not change the phenotype of DCs, but stimulates their ability to induce the expansion of CD25+
FOXP3+CD4+ T lymphocytes (P , 0.05 versus control).
limitations, reasons for caution: All the experiments were performed in vitro; hence the relevance of our observations should
be validated in vivo.
wider implications of the findings: Our results suggest that by inducing the endocytosis of stress-damaged proteins by DCs via
DC-SIGN, seminal plasma clusterin might promote a tolerogenic response to male antigens, thereby contributing to female tolerance to seminal
antigens.
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Introduction
Clusterin is a ubiquitous glycoprotein of 75–80 kDa present in almost all
tissues and body fluids. It is highly conserved among mammals showing
70–80% identity at the amino acid level. Although clusterin appears to
be involved in a variety of physiological and pathological processes,
such as cell death regulation, complement inhibition, Alzheimer’s
disease and cancer progression, its function is still controversial and en-
igmatic (Jones and Jomary, 2002; Wu et al., 2012; Niforou et al., 2014).
Clusterin was the first extracellular chaperone described (Wilson and
Easterbrook-Smith, 2000). Other well-characterized extracellular cha-
perons are haptoglobin and a-2 macroglobulin (Yerbury et al., 2005;
Wyatt et al., 2013a,b). Extracellular chaperones bind to stress-damaged
proteins, preventing the formation and deposition of insoluble aggre-
gates and promoting the clearance of extracellular stressed proteins by
receptor-mediated endocytosis followed by lysosomal degradation
(Wyatt et al., 2013a,b). Failure of these mechanisms contributes to the
development of the so-called protein deposition diseases such as amyl-
oidosis, atherosclerosis, Alzheimer’s or Creutzfeldt–Jakob diseases
(Wyatt et al., 2013a,b). Clusterin is able to interact with a variety of pro-
teins after exposure to different stressors like heating, oxidative damage,
chemical reducing agents or shear stress (Wyatt et al., 2009a,b). Al-
though the structure of clusterin has not been fully resolved, it is pre-
dicted to contain three amphipathic alpha-helices which may interact
with hydrophobic regions that become surface-exposed in stressed pro-
teins (Bailey et al., 2001). The chaperone activity of clusterin is
ATP-independent and results in the formation of high molecular
weight complexes with misfolded proteins (Wyatt et al., 2009a,b).
Clusterin is a highly glycosylated protein with 30% of its molecular
mass contributed by glycans (Kapron et al., 1997; Jones and Jomary,
2002). The concentration of clusterin in human blood plasma is
around 100 mg/ml while the concentration in semen is at least 20-fold
higher (i.e. 2–10 mg/ml), raising the question about the role of
seminal plasma clusterin in reproduction (Choi et al., 1990). We have
previously reported that seminal plasma clusterin bears highly fucosy-
lated Lewis X and Lewis Y type glycans which confer clusterin the
ability to bind with high affinity to DC-SIGN, a C-type lectin receptor se-
lectively expressed on dendritic cells (DCs) (Sabatte et al., 2011). Intri-
guingly, the glycosylation pattern of serum clusterin is different from its
semen counterpart, bearing mostly sialylated glycans (Kapron et al.,
1997). Indeed, in contrast with seminal plasma clusterin, serum clusterin
does not interact with DC-SIGN (Sabatte et al., 2011).
Here we show that seminal plasma clusterin not only displays a chap-
erone activity similar to serum clusterin, but also targets stressed pro-
teins to DCs via DC-SIGN. Clusterin clients are then endocytosed and
sorted to intracellular degradative compartments involved in antigen
processing and presentation. We hypothesize that this mechanism
might play a role in the induction of immune tolerance to paternal anti-
gens required for normal pregnancy. It should be emphasized that the ac-
quisition of female tolerance against seminal antigens requires the
stimulation of an active tolerogenic response which involves the partici-
pation of both tolerogenic DCs and regulatory T cells (Tregs) (Steinman
et al., 2003; Aluvihare et al., 2004; Moldenhauer et al., 2009; Robertson
et al., 2013). In this regard, it has been shown that exposure of the female
genital mucosa to seminal plasma triggers the expansion of Tregs in drain-
ing lymph nodes (Robertson et al., 2009). Moreover, we recently
reported that seminal plasma induces the differentiation of DCs into a
tolerogenic profile (Remes Lenicov et al., 2012). Of note, the induction
of a state of tolerance against seminal antigens requires the interaction
and endocytosis of seminal antigens by DCs. Our present results
suggest that seminal plasma clusterin might play a role in these processes
by promoting the endocytosis of stressed seminal antigens by DCs via
DC-SIGN. Supporting that this novel pathway of antigen uptake might
be associated with the induction of tolerance rather than immunity, we
found that the interaction of seminal plasmaclusterinwith DC-SIGN pro-
motes the ability of DCs to stimulate the expansion of CD25+FOXP3+
CD4+ T cells. Interestingly, a similar tolerogenic response was induced
by other compounds found in semen at unusually high concentrations,
such as transforming growth factor (TGF)-b and prostaglandin E2
(Robertson and Sharkey, 2001; Moldenhauer et al., 2009; Robertson
et al, 2013), further suggesting that seminal antigens picked up by DCs
through DC-SIGN will induce tolerance rather than immunity.
Materials and Methods
Reagents
Catalase, Glutathione-S-transferase (GST) and Bovine Serum Albumin (BSA)
were obtained from Sigma-Aldrich (USA). Antibodies against DC-SIGN
were obtained from the AIDS Research and Reference Reagent Program,
Division of AIDS, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, MD, USA (clones 120507 and 120526) and
from R&D Systems (USA) (clone 120612). Polyclonal goat antibodies
against clusterin were from R&D Systems (USA).
Seminal plasma samples
All protocols using human cells and semen samples were approved by the
Ethical Committee of the National Academy of Medicine (Buenos Aires, Ar-
gentina). Seminal plasma samples were collected from healthy donors (aged
25–45 years) as previously described (Sabatte et al., 2007). Informed
consent was obtained from each patient before sperm collection. Ejaculates
were obtained by masturbation under hygienic conditions, after a period of
2–4 days of sexual abstinence, and were collected in sterile containers.
The samples were allowed to liquefy for 30 min at 378C. Seminal plasma
was separated from the cell fraction by centrifugation (15000×g, 30 min at
48C), and the supernatant was passed through a 0.22 mm-pore-size
syringe filter (Millipore, The Netherlands) and stored at 2808C until use.
Purification of clusterin
Purification was performed by affinity chromatography as described (Sabatte
et al., 2011), using anti-clusterin antibodies coupled to an N-hydroxysuccinimide
(NHS)-activated HiTrap column. Briefly, a pool of 5 ml of seminal plasma col-
lected from five different donors was diluted 1/10 in phosphate-buffered
saline (PBS) in the presence of a complete protease inhibitor mixture (Roche,
Germany). The sample was continuously recirculated through the column,
using a peristaltic pump, for 16 h at 48C. Then, the column was washed with













100 ml of PBS and the retained material was eluted with glycine 0.1 M at pH 2.8.
Purified clusterin was dialyzed twice against 1 l of PBS for 16 h at 48C, concen-
trated, and finally analyzed by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (under reducing or non-reducing conditions) and Coomassie staining
(LabSafe Gel blue; G-Bioscience, USA) (Supplementary Fig. S1). The concentra-
tion of clusterin stocks was determined by enzyme-linked immunosorbent assay
(R&D Systems, USA).
Protein precipitation assays
Solutions of catalase (200 mg/ml), GST (400 mg/ml) and human serum
(diluted 1/10 in PBS) were prepared in PBS and heated at 608C in the pres-
ence or absence of seminal plasma or serum clusterin (100 mg/ml). The light
scattering of the solution at 360 nm was measured every 1 min for 20 min in a
Bio Rad SmartSpect 3000 (USA). Catalase (200 mg/ml), GST (400 mg/ml)
or BSA (500 mg/ml), were incubated at 378C for 120 min in PBS containing
dithiothreitol (DTT, 20 mM), in the absence or presence of seminal plasma
or serum clusterin (at concentrations of 200, 400 or 500 mg/ml, for catalase,
GST and BSA, respectively). The light scattering of the solutions at 360 nm
was measured every 8 min.
Cell lines
Human Raji cells, an Epstein Barr Virus-positive Burkitt’s lymphoma-derived
cell line, and DC-SIGN-expressing Raji cells were obtained from the AIDS
Research and Reference Reagent Program, MD, USA, and grown in complete
medium: RPMI 1640 medium supplemented with 10% heat-inactivated fetal
bovine serum, 50 U of penicillin/ml and 50 mg of streptomycin/ml (Gibco,
USA).
Preparation of human DCs
Peripheral blood mononuclear cells were isolated from blood of healthy
donors by density gradient centrifugation using Ficoll-Hypaque (GE Health-
care, Sweden). Monocytes were obtained using CD14 microbeads (Miltenyi
Biotec, Germany). To obtain DCs, monocytes were cultured for 5 days at a
final concentration of 1 × 106 cells/ml in complete medium supplemented
with 20 ng/ml of interleukin (IL)-4 and 20 ng/ml of granulocyte-macrophage
colony-stimulating factor (GM-CSF) (Miltenyi Biotec, Germany). On Day 5,
the cells were analyzed by fluorescence-activated cell sorter (FACS).
Binding of stressed proteins to DC-SIGN
expressing Raji cells and DCs
Binding assays were carried out as follows: first, biotin-labeled catalase
(200 mg/ml) or GST (400 mg/ml), or mixtures of clusterin (100 mg/ml)
with catalase or GST were heated for 20 min at 608C or incubated at 48C
(controls). Then, the solutions were cooled and 20 ml of each solution
were added to Raji cells, DC-SIGN expressing Raji cells or DCs (5 × 105
cells in 40 ml of complete medium), and incubated for 60 min at 48C. The
cells were then washed twice with cold complete medium, stained with fluor-
escein isothiocyanate (FITC)-conjugated streptavidin and analyzed by flow
cytometry. Binding assays were also carried out with a solution of biotin-
labeled BSA (500 mg/ml) stressed by heating at 378C for 150 min with
DTT (20 mM), in the absence or presence of clusterin (500 mg/ml). In
some experiments, cells were pre-treated for 30 min at 48C with mannan
(1 mg/ml), DC-SIGN blocking antibodies (10 mg/ml) or mouse immuno-
globulin G as a control.
Enzymatic treatment of clusterin
Clusterin purified from seminal plasma (3–10 mg) was treated with 50 mU of
a1–2 fucosidase or 0.5 mU ofa1-3,4 fucosidase (Calbiochem, USA) for 3 h
at 378C in 50 mM sodium phosphate buffer (pH 5).
Flow cytometry
FITC or phycoerythrin-conjugated monoclonal antibodies (mAbs) directed
to CD40, CD80, CD86, HLA-DR, CD83 and CD209 (DC-SIGN) were
from BD Pharmingen (USA). In all cases isotype-matched control antibodies
were used. Analysis was performed using a BD FACSCanto cytometer and
BD FACSDiva software (BD Biosciences, USA).
Endocytosis assays
Mixturesof clusterin (100 mg/ml) with catalase (200 mg/ml) were heated for
20 min at 608C. Then, 20 ml of these solutions were added to DCs (5 × 105
cells in 40 ml of complete medium) and incubated for 60 min at 48C. Then,
cells were washed twice using cold complete medium and stained with FITC-
conjugated streptavidin for 15 min at 48C. Cells were washed, incubated for
30 min at 37 or 48C and then analyzed by flow cytometry in the presence or
absence of Trypan Blue (20% v/v).
Confocal microscopy analysis
DCs were placed on poly-L-lysine–coated glass coverslips (12 mm) for
30 min at room temperature. Binding assays were carried out as follows:
biotin-labeled catalase (200 mg/ml) was heated for 20 min at 608C in the
presence of clusterin (100 mg/ml), the solution was cooled, added to DCs
and incubated for 60 min at 48C. After that, cells were washed and the cover-
slips were covered with 100 ml of complete medium and incubated at 378C
for 15 min or 30 min to allow endocytosis. The cells were washed with PBS
and fixed in 4% paraformaldehyde for 15 min on ice. Then, cells were treated
with 0.1 mM glycine in PBS and incubated with mAbs directed to early
endosome antigen 1 (EEA1), lysosome-associated membrane protein 1
(LAMP-1), clusterin or DC-SIGN for 1 h, washed and stained with conju-
gated secondary antibodies (Jackson Immuno Research, USA). Coverslips
were mounted on glass slides using Fluoromount G. Immunofluorescence
images were acquired with a FluoView FV1000 confocal microscope
(Olympus, USA) using a Planapo 60x 1.42 NA immersion objective.
Analysis of CD251FOXP31 CD41 T cell
expansion by DCs
CD4+ T cells were purified by using a CD4+ T cell isolation kit (Miltenyi).
DCs (5.104/100 ml) were incubated with seminal plasma clusterin (40 mg/ml)
or PBS and cultured for 24 h in complete medium containing 20 ng/ml of IL-4
and 20 ng/ml of GM-CSF. DCs were then washed and cultured with allogeneic
CD4+ T cells (2.105/100 ml) for 5 additional days in complete medium into
U-shaped culture plates. After this period cells were stained using antibodies
directed to CD4, CD25 and FOXP3, following manufacturer’s instructions
(BD Biosciences, USA), and analyzed by flow cytometry.
Statistical analysis
Statistical analyses were performed using GraphPad Prism software (La Jolla,
CA, USA). Statistical comparisons of two groups were performed by using
paired t-test. Statistical comparisons for multiple groups were performed
by using analysis of variance followed by Bonferroni’s multiple comparison
post test. The P-values ,0.05 were considered statistically significant.
Results
Seminal plasma clusterin has chaperone
activity
We first analyzed whether seminal plasma clusterin was able to display
chaperone activity, as was described for serum clusterin (Wilson and
Easterbrook-Smith, 2000; Yerbury et al., 2007; Wyatt et al., 2009a,b,













2011; Wyatt and Wilson, 2010). To this aim, clusterin was purified from
seminal plasma or serum samples. Its ability to prevent the precipitation of
stressed-proteins was evaluated by measuring the absorbance at 360 nm.
Figure 1A–C and G showsthe effect of seminal plasmaclusterin (CLU)
and serum clusterin (serum-CLU) on the precipitation of catalase, GST,
and normal human serum, induced by heating at 608C, while Fig. 1D–F
and H shows the effect of clusterin on the precipitation of catalase, GST,
and BSA, induced by treatment with DTT, as previously described (Hum-
phreys et al., 1999). The results indicated that seminal plasma clusterin
significantly inhibited the precipitation of all the proteins assessed, in a
similar fashion than serum clusterin. We conclude that seminal plasma
clusterin has chaperone activity.
Figure 1 Seminal plasma clusterin has chaperone activity. (A–C) Catalase (200 mg/ml), GST (400 mg/ml) or human serum (diluted 1 in 10 in
phosphate-buffered saline), were incubated for 20 min at 608C in the presence or absence of seminal plasma clusterin (CLU) (100 mg/ml) or serum clus-
terin (serum-CLU) (100 mg/ml). (D–F) Catalase (200 mg/ml), GST (400 mg/ml) or bovine serum albumin (BSA) (500 mg/ml), were incubated for
120 min at 378C in a buffer containing dithiothreitol (DTT) (20 mM) in the presence or absence of CLU or serum-CLU, at concentrations of 200, 400,
or 500 mg/ml, for catalase, GST, and BSA, respectively. Absorbance at 360 nm was measured at different time points. Squares (B) represent controls,
triangles (O) represent proteins incubated with CLU and circles (W) represent proteins incubated with serum-CLU. Representative experiments are
shown (n ¼ 3–6). (G and H) Experiments in (G) and (H) were performed as described above for (A)–(C) (20 min at 608C), and (D)–(F) (120 min at
378C with DTT 20 mM), respectively. Results are expressed as the mean+ SEM of 3–6 experiments. The absorbance of stressed-proteins incubated
with CLU or serum-CLU was expressed as the percentage of the absorbance of proteins stressed in the absence of clusterin (CONTROL). *P , 0.01
versus CONTROL (student’s t-test).













Seminal plasma clusterin targets extracellular
stressed proteins to DC-SIGN
We have previously reported that human seminal plasma clusterin binds to
DC-SIGNonDCswithhighaffinity (Kd76 nM)(Sabatteetal., 2011).We
hypothesize that seminal plasma clusterin might target stressed proteins to
DC-SIGN on DCs influencing the adaptive immune response to seminal
antigens. To test this hypothesis we first analyzed the ability of seminal
plasma clusterin to induce the binding of biotin-labeled stressed catalase
to DC-SIGN-expressing Raji cells. The expression of DC-SIGN by Raji
cells is illustrated in Fig. 2A. In these experiments biotin-labeled catalase
(200 mg/ml) was incubated for 20 min at 608C (stressed catalase) or
48C with or without seminal plasma clusterin (100 mg/ml). Then, the
bindingofcatalasetoRaji cellswas revealedusingFITC-labeledstreptavidin.
When stressed in the presence of seminal plasma clusterin, catalase
efficiently binds to DC-SIGN-expressing Raji cells (Fig. 2B) but not to
DC-SIGN (2) Raji cells (Fig. 2C), the binding being completely pre-
vented by the DC-SIGN inhibitor mannan (Fig. 2D). As expected, not
only stressed catalase, but also stressed GST and BSA were efficiently
carried by seminal plasma clusterin to DC-SIGN (Fig. 2E–G). Serum
clusterin does not interact with DC-SIGN (Sabatte et al., 2011) and con-
sequently it did not induce the binding of stressed proteins to DC-SIGN-
expressing Raji cells (Fig. 2E–G).
We then analyzed the ability of seminal plasma clusterin to target
stressed proteins to DC-SIGN expressed on DCs. The expression of
DC-SIGN by DCs is illustrated in Fig. 3A. Seminal plasma clusterin effi-
ciently targeted stressed catalase to DCs (Fig. 3B). Both, mannan and
three different anti-DC-SIGN antibodies that recognize and block the
carbohydrate recognition domain of DC-SIGN markedly inhibited the
binding of stressed-catalase to DCs (Fig. 3C–F). This indicates that
DC-SIGN is the main receptor for clusterin-client protein complexes
on DCs. Moreover, consistent with our previous observations indicating
that seminal plasma clusterin binds to DC-SIGN trough Lewis type ter-
minal fucose motifs (Sabatte et al, 2011), we found that the treatment
of seminal plasma clusterin with a1-3,4 fucosidase or a1-2 fucosidase
inhibited its ability to target stressed-catalase to DCs (Fig. 3G and H).
Figure 2 Clusterin targets stressed proteins to DC-SIGN. (A) Raji DC-SIGN (+) cells were stained using fluorescein isothiocyanate (FITC)-conjugated
anti-DC-SIGN antibodies and analyzed by flow cytometry. Black histogram represent the isotype control. (B–D) Biotin-labeled catalase (200 mg/ml) was
incubated for 20 min at 60 or 48C with or without CLU (100 mg/ml). The binding of catalase to DC-SIGN (+) Raji cells (B) or DC-SIGN (2) Raji cells (C)
was analyzed by incubating cells with biotin-labeled catalase/clusterin complexes for 60 min at 48C. Cells were then washed and the binding of biotin-
labeled catalase/clusterin complexes was revealed by flow cytometry using FITC-streptavidin. In (D), Raji DC-SIGN+ cells were pre-treated for
30 min at 48C with mannan (1 mg/ml) to block DC-SIGN. Then, the binding of biotin-labeled catalase/clusterin complexes was assessed as described
for (B) and (C). Representative histograms are shown (n ¼ 4). (E and F) Biotin-labeled catalase (200 mg/ml) or GST (400 mg/ml) were incubated for
20 min at 60 or 48C in the absence or presence of CLU (100 mg/ml). Then, catalase and GST were incubated for 60 min at 48C with DC-SIGN-expressing
Raji cells, pre-treated, or not, with mannan (1 mg/ml). Binding of biotin-labeled catalase or GST was revealed by flow cytometry using FITC-streptavidin.
Binding of catalase stressed at 608C in the presence of CLU was considered as 100%. Results are the mean+ SEM of three experiments (*P , 0.01). (G)
Biotin-labeled BSA (500 mg/ml) was incubated for 60 min at 378C with DTT (20 mM) in the absence or presence of CLU (500 mg/ml). Binding of biotin-
labeled BSA was assessed as described in (E) and (F). Results are the mean+ SEM of three experiments (*P , 0.01, analysis of variance (ANOVA)).













As expected, serum clusterin was shown to be completely unable to
target stressed catalase to DCs (Fig. 3I– J).
Seminal plasma clusterin induces the
endocytosis of stressed proteins by DCs
Because binding to DC-SIGN results in the internalization of their ligands
(Engering et al., 2002; Geijtenbeek and van Kooyk, 2003; Cambi et al.,
2009), we next analyzed the ability of seminal plasma clusterin to
induce the endocytosis of stressed proteins and the endocytic pathway
followed by them. In a first set of experiments, we took advantage of
the ability of the colorant trypan blue to quench the green fluorescence
of extracellularproteins attached to the cell surface (Sahlin et al., 1983). In
these experiments, biotin-labeled catalase was stressed in the presence
of seminal plasma clusterin for 20 min at 608C and then incubated with
DCs for 60 min at 48C. Cells were then washed, stained at 48C using
FITC-conjugated streptavidin and incubated for an additional period of
30 min at 4 or 378C, to allow catalase endocytosis. Trypan blue almost
completely quenched fluorescence in cells cultured at 48C (Fig. 4A)
but only slightly quenched fluorescence in cells cultured at 378C
(Fig. 4B), indicating that catalase was efficiently internalized. As expected,
studies performed by confocal microscopy revealed the colocalization of
clusterin and catalase inside DCs (Fig. 4C).
Figure 3 Clusterin targets stressed proteins to dendritic cells. (A) Dendritic cells (DCs) were stained using FITC-conjugated anti-DC-SIGN antibodies
and analyzed by flow cytometry. Black histogram represent the isotype control (B–H). Biotin-labeled catalase (200 mg/ml) was incubated in the absence or
presence of CLU (100 mg/ml) at 60 or 48C. Then, the binding of biotin-labeled catalase to DCs was analyzed by flow cytometry using FITC-streptavidin. In
(C), DCs were pre-treated, or not, with mannan for 30 min at 48C, to block DC-SIGN. Representative histograms (n ¼ 3) are shown in (B) and (C), and the
mean+ SEM of three independent experiments are shown in (D). In (E) and (F), DCs were pre-treated, or not, with three different blocking antibodies
directed to DC-SIGN (from left to right in F: clones 120507, 120526 and 120612). Representative histograms (n ¼ 3) are shown in (E) and the mean+ SEM
of three independent experiments are shown in (F) (*P , 0.01). In (G) and (H), assays were performed using biotin-labeled catalase (200mg/ml) stressed in
the presence of CLU (100 mg/ml), previously treated, or not, witha1-3, 4 ora1-2 fucosidase. Representative histograms (n ¼ 3) are shown in (G) and the
mean+ SEM of three independent experiments are shown in (H) (*P , 0.01). (I and J) Biotin-labeled catalase (200 mg/ml) was incubated in the absence
(Control) or presence of CLU (100 mg/ml) or serum-CLU (100 mg/ml) for 20 min at 608C. Then, the binding of biotin-labeled catalase to DCs was ana-
lyzed by flow cytometry using FITC-streptavidin. Representative histograms (n ¼ 3) are shown in (I) and the mean+ SEM of three independent experi-
ments are shown in (J) (*P , 0.01 versus control, ANOVA test).













Figure 4 Clusterin-client complexes are endocytosed by DCs. Biotin-labeled catalase (200 mg/ml) was incubated at 608C for 20 min with CLU
(100 mg/ml). Then, the solution was cooled and incubated with DCs for 60 min at 48C. Cells were washed and stained using FITC-conjugated streptavidin.
After washing, cells were cultured for an additional period of 30 min at 48C (A) (to prevent endocytosis) or at 378C (B) (to allow endocytosis). Finally, cells
were analyzed by flow cytometry in the presence or absence of trypan blue. Representative histograms (n ¼ 3) are shown. In (C), endocytosis of stressed
catalase induced by CLU was analyzed by confocal microscopy. Biotin-labeled catalase (200 mg/ml) was incubated at 608C during 20 min with CLU
(100 mg/ml). Clusterin-catalase complexes were then incubated with DCs for 60 min at 48C. After washing, cells were treated with fluorescent-labeled
streptavidin for 30 min at 48C. Finally, cells werewashed, incubated for 15 min at 378C to allowendocytosis, fixed and stained using anti-clusterin antibodies
and fluorescent-labeled secondary antibodies. Colocalization of catalase and CLU was analyzed by confocal microscopy. Representative images are shown
at ×300 magnification (n ¼ 5).













To define the fate of endocytosed proteins targeted by clusterin, the
endocytic route of biotin-labeled catalase was followed using endosome
specific markers that distinguish between early and late endosomes/
lysosomes: early EEA1 and LAMP-1, respectively. As shown in Fig. 5A,
catalase colocalized with DC-SIGN at the cell surface at 5 min, but not
at 30 min of endocytosis (Fig. 5A), the time at which most of the catalase
exhibited an intracellular localization. Co-localization of catalase with
EEA1 and LAMP-1 was evident at 15 and 30 min of endocytosis, respect-
ively (Fig. 5B and C), suggesting that catalase is sorted to late endosomes
for degradation.
Seminal plasma clusterin improves the ability
of DCs to promote the expansion of
CD251FOXP31CD41 T cells
Considering previous observations indicating that DC-SIGN-mediated
signaling promotes the differentiation of DCs into a tolerogenic profile
(Gringhuis et al., 2007, 2009), we analyzed whether besides the ability
of seminal plasma clusterin to interact with stressed proteins and
target them to DC-SIGN, it might also be capable of modulating the
phenotype and function of DCs. To address this aim, DCs were cultured
for 24 h with or without lipopolysaccharide (LPS), in the absence or pres-
ence of seminal plasma clusterin, and the phenotype of DCs was then
analyzed by flow cytometry. Figure 6A shows that seminal plasma clus-
terin did not modify the expression of HLA-DR, CD83, CD80, CD86,
CD40 and DC-SIGN in resting or LPS-treated DCs. Additional experi-
ments were performed to analyze whether seminal plasma clusterin
was able to modulate the expansion of regulatory T cells (CD25+
FOXP3+CD4+ T cells) induced by DCs in the mixed leukocyte reac-
tion (MLR). To this aim, DCs were incubated with or without seminal
plasma clusterin (40 mg/ml) for 24 h, washed and cultured with allogen-
eic CD4+ T cells for 5 days, and the presence of regulatory T cells was
analyzed by flow cytometry.
As shown in Fig. 6B and C, seminal plasma clusterin stimulated the ex-
pansion of CD25+FOXP3+CD4+ T cells in the MLR. No effect was
observed when CD4+ T cells were cultured with seminal plasma clus-
terin (40 mg/ml) without allogeneic DCs, either in the absence (not
shown) or presence of anti-CD3 (1.2 mg/ml) and anti-CD28 (1 mg/
ml) antibodies, used to induce T cell activationand proliferation:percent-
age of CD25+FOXP3+CD4+ T cells ¼ 14.4+4.2 versus 16.9+3.9,
for T cells cultured with or without seminal plasma clusterin, respectively
(n ¼ 3). This suggests that seminal plasma clusterin stimulates the expan-
sion of CD25+FOXP3+CD4+ T cells by promoting the acquisition of a
tolerogenic profile by DCs.
Discussion
In this study we showed that human seminal plasma clusterin has chap-
erone activity and targets stressed proteins to DC-SIGN. Binding of
clusterin-client complexes to DC-SIGN was observed using concentra-
tions of clusterin 50 to 100 fold lower than those normally found in semen
(Choi et al., 1990). DC-SIGN was shown to be the main receptor for
clusterin-client complexes on DCs, in fact, mannan and three different
blocking antibodies directed to DC-SIGN almost completely prevented
the binding of clusterin-client complexes to DCs. After binding, these
complexes were internalized by DCs into EEA1-positive compartments
and then sorted into LAMP1-positive late endosomes, a pathway
employed by DCs to process and present internalized antigens to
prime T cells.
Clusterin was the first extracellular chaperone described (Humphreys
et al., 1999). Extracellular chaperones bind to stressed misfolded pro-
teins inhibiting the formation of insoluble aggregates, maintaining their
solubility and preventing their inherent toxic effects (Wyatt et al.,
2013a,b). Moreover, extracellular chaperones promote the clearance
of misfolded proteins delivering them to specific cellular receptors for
endocytosis and intracellular degradation (Wyatt et al., 2013a,b). In
this regard, it has been shown that clusterin-amyloid b-peptide com-
plexes bind to the receptor megalin (also called LRP2) being subsequent-
ly internalized and degraded (Hammad et al., 1997). However, in
contrast with the ubiquitous expression of clusterin, megalin is only
expressed at the proximal tubules of the kidney, in the choroid plexus
epithelium and in ependymal cells lining the brain ventricles (Lundgren
et al., 1997). On the other hand, scavenger receptors appear also to
be able to mediate the clearance of systemic clusterin-client complexes
(Wyatt et al., 2011). The function of seminal plasma clusterin as an extra-
cellular chaperone appears to be quite different from its serum counter-
part. First, the chaperone activity of seminal plasma clusterin is confined
to two major scenarios, the male and the female genital tracts. Second,
because DC-SIGN is selectively expressed by DCs, which express the
unique ability to activate naı̈ve T cells (Guermonprez et al., 2002), the
most important function of seminal plasma clusterin might not be
related to the clearance of stressed proteins from the extracellular
space, but rather it might be related to the targeting of stressed proteins
to DC-SIGN in order to promote antigen presentation. In this regard, it
should be emphasized that antigen presentation results not only in im-
munity, but also in tolerance, depending on the functional profile of
DCs (Steinman et al., 2003).
PreviousstudieshaveshownthatDC-SIGNnotonlymediatesthe intern-
alization of extracellular ligands, but also modulates the functional profile of
DCs (Geijtenbeek and Gringhuis, 2009). A large body of evidence indicates
that the interaction of DC-SIGN with a variety of ligands, such as measles
virus (Mesman et al., 2014), Helicobacter pylori (Gringhuis et al., 2009),
myelinoligodendrocyteglycoprotein (Garcia-Vallejoetal., 2014), andthera-
peutic preparations of immunoglobulins such as intravenousgammaglobulin
(IVIG) (Anthony et al., 2011), promotes the acquisition of a tolerogenic
profile by DCs. Recent studies, on the other hand, have revealed that
ligation of DC-SIGN could also promote the differentiation of CD4+ T
cells into a T follicular helper (Gringhuis et al., 2014a,b) or T helper 2 profile
(Gringhuis et al., 2014a,b). In line with these observations we found that,
even when seminal plasma clusterin did not modify the phenotype of DCs
evaluated by the expression of HLA-DR, CD80, CD86, CD40, DC-SIGN
and CD83, it stimulates the ability of DCs to expand CD25+FOXP3+
CD4+ T cells, a phenotype usually associated with regulatory T cells
(Sakaguchi et al., 2010). This suggests that antigens carried out by seminal
plasma clusterin to DC-SIGN might induce tolerance rather than immunity.
Besides clusterin, human seminal plasma contains other DC-SIGN
ligands: galectin-3 binding protein, prostatic acid phosphatase, protein
C inhibitor (Clark et al., 2012), and mucin 6 (Stax et al., 2009). None
of these ligands display a chaperone-like activity; however, all of them
might promote the differentiation of DCs into a tolerogenic profile by
interacting with DC-SIGN. The acquisition of a tolerogenic profile by
DCs induced by DC-SIGN ligands might be important in two distinct
scenarios. In the female genital tract, it might induce maternal tolerance
to male alloantigens. Moreover, it could also playa role in the male genital













tract. It is well known that neoantigens in the semen are produced during
puberty, long after the establishment of systemic self-tolerance (Kour-
ilsky and Claverie, 1989). However, immune response against these
neoantigens is not evoked (Fijak and Meinhardt, 2006). Considering
that in the mammalian reproductive tract clusterin is produced not
only by the epididymis, seminal vesicle, and prostate, but also by the
testis (Sylvester et al., 1991; O’Bryan et al., 1994; Ahuja et al., 1996),
we speculate that it might promote the acquisition of a tolerogenic
profile by DCs contributing to testicular immune privilege.
The tolerogenic properties of semen are not only related to the pres-
ence of clusterin and other DC-SIGN ligands. Semen contains huge con-
centrations of regulatory T cell-inducing agents such as TGF-b and
prostaglandins (Robertson et al., 2002; Remes Lenicov et al., 2014).
Moreover, Robertson and co-workers have shown that exposure of
the female genital mucosa to semen promotes the expansion of CD25+
FOXP3+CD4+ Tregs in the lymph nodes draining the uterus, favoring
tolerance to male alloantigens in mice (Guerin et al., 2011; Robertson
et al., 2013). Interestingly, this response is induced even in the absence
Figure 5 Analysis of clusterin-client containing compartments in DCs. Biotin-labeled catalase (200 mg/ml) was incubated at 608C for 20 min with CLU
(100 mg/ml). Clusterin-catalase complexes were then incubated with DCs for 60 min at 48C, washed and stained using fluorescent-labeled streptavidin.
After this period, cells were incubated at 378C for 5 min (A, upper panel), 15 min (B and C, upper panels) or 30 min (A, B, and C, lower panels) to allow
endocytosis, fixed and stained using antibodies directed to DC-SIGN (A), endosome antigen 1 (EEA1) (B) or lysosome-associated membrane protein 1
(LAMP1) (C). Nuclear counterstain with DAPI was used in (A). Representative images are shown at ×300 magnification (n ¼ 3–5).













of conception, thus suggesting an important role for semen as a Treg
inducer (Moldenhauer et al., 2009).
Seminal plasma is more than just a spermatozoa carrier. It induces
strong immunomodulatory effects at the female genital tract. Deposition
of semen in female reproductive mucosa not only promotes the expan-
sion and recruitment of regulatory T cells, but also triggers the activation
of an acute and strong inflammatory response leading to the production
of inflammatory cytokines and chemokines and the recruitment of large
Figure 6 Clusterin stimulates the ability of DCs to expand CD25+FOXP3+CD4+ T cells. (A) DCs (1 × 106/ml) were cultured for 24 h in the absence
(gray histograms) or presence of CLU (40 mg/ml) (dotted histograms), with or without lipopolysaccharide (LPS) (10 ng/ml). The expression of HLA-DR,
CD80, CD86, CD83, CD40 and DC-SIGN was then analyzed by flow cytometry. Isotype controls are shown in black. Representative histograms (n ¼ 3)
are shown. (B and C) DCs (5 × 104/100 ml) were incubated with or without CLU (40 mg/ml) for 24 h, washed and cultured with allogenic T cells (DC: T
cell ratio ¼ 1:4), as described in Materials and Methods. After 5 days the percentage of CD25+FOXP3+CD4+ T cells was determined by flow cytometry.
In (B), a representative dot plot is shown. In (C), the results from four independent experiments using different cell donors are shown (* ¼ P , 0.05, stu-
dent’s t-test).













numbers of neutrophils and DCs (Robertson et al., 2006; Sharkey et al.,
2007, 2012). This inflammatory response might result in the generation
of oxygen free radicals and the oxidative damage of semen proteins at the
female genital tract. In this scenario, the ability of seminal plasma clusterin
to target seminal proteins to DC-SIGN as well to promote a tolerogenic
response against male antigens would be strengthened.
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Supplementary data areavailable athttp://humrep.oxfordjournals.org/.
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